Advanced search
Publication Cover
International Journal of General Medicine Volume 17, 2024 - Issue
Submit an article Journal homepage
84
Views
0
CrossRef citations to date
0
Altmetric
Hematology

Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassaemia: A Single-Center Experience

Weijian Zhu1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2120-5860View further author information
ORCID Icon,
Ying He1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaView further author information
,
Mufang Huang1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaORCID Iconhttps://orcid.org/0009-0000-9225-3176View further author information
ORCID Icon,
Shezhu Fu1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaView further author information
,
Ziyi Liu1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaView further author information
,
Xiaoqi Wang1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaView further author information
,
Zhixin Li1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaView further author information
,
Xiaoliang Li1 Department of Hematology, Zhuhai Clinical Medical College of Jinan University (Zhuhai People’s Hospital), Zhuahai, 519050, People’s Republic of ChinaView further author information
,
Jiangming Chen2 Department of Haematology, Wuzhou Gongren Hospital, Wuzhou, 543001, People’s Republic of ChinaView further author information
&
Yangqiu Li3 Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 10632, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0974-4036View further author information
ORCID Icon show all
Pages 1729-1738 | Received 12 Mar 2024, Accepted 24 Apr 2024, Published online: 01 May 2024

References

  • Kountouris P, Lederer CW, Fanis P, Feleki X, Old J, Kleanthous M. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020. doi:10.1371/journal.pone.0103020
  • Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331–4336. doi:10.1182/blood-2010-01-251348
  • Aydinok Y. Thalassemia. Hematology. 2012;17(sup1):s28–s31. doi:10.1179/102453312X13336169155295
  • Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in β-thalassemia. Blood Rev. 2019;37:100588. doi:10.1016/j.blre.2019.100588
  • Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167. doi:10.1016/S0140-6736(17)31822-6
  • Persons DA. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders. ASH Education Program Book. 2009;2009(1):690–697. doi:10.1182/asheducation-2009.1.690
  • Michlitsch JG, Walters MC. Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mole Med. 2008;8(7):675–689. doi:10.2174/156652408786241393
  • Thompson AA, Walters MC, Kwiatkowski J, et al. Gene therapy in patients with transfusion-dependent β-thalassemia. N Engl J Med. 2018;378(16):1479–1493. doi:10.1056/NEJMoa1705342
  • Musallam KM, Sankaran VG, Cappellini MD, Duca L, Nathan DG, Taher AT. Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia. Blood. 2012;119(2):364–367. doi:10.1182/blood-2011-09-382408
  • Ansari SH, Shamsi TS, Ashraf M, et al. Efficacy of hydroxyurea in providing transfusion Independence in β-thalassemia. J Pediatr Hematol. 2011;33(5):339–343.
  • Chen J, Zhu W, Cai N, Bu S, Li J, Huang L. Thalidomide induces haematologic responses in patients with β‐thalassaemia. Eur J Haematol. 2017;99(5):437–441. doi:10.1111/ejh.12955
  • Li X, Hu S, Liu Y, et al. Efficacy of thalidomide treatment in children with transfusion dependent β-thalassemia: a retrospective clinical study. Front Pharmacol. 2021;12:722502. doi:10.3389/fphar.2021.722502
  • Jain M, Chakrabarti P, Dolai TK, et al. Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia-a pilot study from a tertiary care Centre of India. Blood Cells. 2021;88:102544. doi:10.1016/j.bcmd.2021.102544
  • Li Y, Ren Q, Zhou Y, Li P, Lin W, Yin X. Thalidomide has a significant effect in patients with thalassemia intermedia. Hematology. 2018;23(1):50–54. doi:10.1080/10245332.2017.1354427
  • Chen J-M, Zhu W-J, Liu J, et al. Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial. Sig Transduct Target Ther. 2021;6(1):1–7. doi:10.1038/s41392-021-00811-0
  • Cappellini MD, Viprakasit V, Taher AT, et al. A Phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia. N Engl J Med. 2020;382(13):1219–1231. doi:10.1056/NEJMoa1910182
  • Musallam KM, Taher AT, Cappellini MD, Sankaran VG. Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. Blood. 2013;121(12):2199–2212. doi:10.1182/blood-2012-10-408021
  • Services UDoHH. Common terminology criteria for adverse events (CTCAE) version 4.0. Nat Instit Health. 2009;4(03):1.
  • Nag A, Radhakrishnan VS, Kumar J, et al. Thalidomide in patients with transfusion-dependent E-beta thalassemia refractory to hydroxyurea: a single-center experience. Indian J Hematol Blood Transfusion. 2020;36(2):399–402. doi:10.1007/s12288-020-01263-2
  • Yang K, Wu Y, Zhou Y, et al. Thalidomide for patients with thalassemia intermedia: a retrospective multicenter clinical study. Mediterr J Hematol Infect Dis. 2020;12(1):e2020021–e2020021. doi:10.4084/mjhid.2020.021
  • Bastuji-Garin S, Ochonisky S, Bouche P, et al. Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol. 2002;119(5):1020–1026. doi:10.1046/j.1523-1747.2002.19502.x

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.